UK markets close in 8 hours 18 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6388-0.0466 (-6.80%)
At close: 04:00PM EDT
0.6350 -0.00 (-0.59%)
After hours: 05:47PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts2232
Avg. Estimate-0.15-0.11-0.5-0.25
Low estimate-0.16-0.12-0.59-0.26
High estimate-0.14-0.11-0.45-0.25
Year ago EPS-0.350.15-0.51-0.5
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts2232
Avg. Estimate46.68M47.97M189.99M209.71M
Low estimate44.37M46.95M181.5M195.31M
High estimate49M49M201.3M224.11M
Year ago sales61.7M126.76M292.6M189.99M
Sales growth (year/est)-24.30%-62.20%-35.10%10.40%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.29-0.31-0.15-0.19
Actual EPS-0.350.15-0.28-0.04
Difference-0.060.46-0.130.15
Surprise %-20.70%148.40%-86.70%78.90%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.15-0.11-0.5-0.25
7 days ago-0.15-0.11-0.5-0.25
30 days ago-0.12-0.11-0.49-0.26
60 days ago-0.12-0.11-0.45-0.26
90 days ago-0.12-0.11-0.45-0.26
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.57.10%N/AN/AN/A
Next qtr.-173.30%N/AN/AN/A
Current year2.00%N/AN/AN/A
Next year50.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A